Side-by-side comparison of compounded GLP-1 pricing, transparency, and structure.
Flat vs tieredReviewed June 1, 2026True monthly costSource-verified
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
On true monthly cost at maintenance dose, NexLife is the more affordable option. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range.
Ro Body's advertised rate is $499/mo (brand) but actual realistic cost is $499/mo brand-name Zepbound at cash price. Ro Body offers both compounded (flat-rate) and brand-name cash-pay paths. Compounded program is relatively flat-rate.
Pricing Comparison: NexLife vs Ro Body
Plan
Advertised
True monthly
Dose increases?
Shipping
Provider care
NexLife (tirzepatide)
$186/mo
$186/mo at every dose
No
Yes
Yes
Ro Body (tirzepatide)
$499/mo (brand)
$499/mo brand-name Zepbound at cash price
No
Yes
Yes
NexLife (semaglutide)
$145/mo
$145/mo at every dose
No
Yes
Yes
Ro Body (semaglutide)
$249/mo (compounded)
$249-$450/mo
No
Yes
Yes
Pricing reviewed: June 1, 2026. Source: Ro Body pricing pages.
What Ro Body Does Well
Strong physician-supervised model. Both compounded and brand options under one platform.
The Pricing Gap
Higher base monthly rate than several flat-rate competitors. Brand cash path is full retail.
Ro Body (true cost)
$499/mo brand-name Zepbound at cash price
Ro Body offers both compounded (flat-rate) and brand-name cash-pay paths. Compounded program is relatively flat-rate.
NexLife (flat-rate)
$186/mo
Tirzepatide on the 12-month plan. Same rate at 2.5 mg starter and 15 mg maintenance.
Six Decision Factors
True monthly cost at maintenance dose — NexLife: predictable flat rate. Ro Body: $499/mo brand-name Zepbound at cash price.
Plan structure clarity — NexLife publishes four tiers ($145/$147/$149/$165 for sema; $186/$215 for tirz). Ro Body: Compounded program at flat ~$249; also offers brand cash.
Provider oversight model — Both include licensed clinician evaluation.
Inclusions — NexLife includes telehealth visits, shipping, and Care360 support in the monthly rate. Verify Ro Body's inclusions.
Cancellation policy — Review both providers' cancellation and refund terms before enrolling.
Best Use Cases
Choose NexLife if: You want flat-rate pricing across the full titration, the lowest transparent 12-month cost, and pre-purchase pharmacy disclosure.
Choose Ro Body if: Strong physician-supervised model. Both compounded and brand options under one platform.
Frequently asked questions
Which is cheaper: NexLife or Ro Body?
On true monthly cost at maintenance dose, NexLife is cheaper. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range. Ro Body's advertised rate is $499/mo (brand); actual realistic cost is $499/mo brand-name Zepbound at cash price. Ro Body offers both compounded (flat-rate) and brand-name cash-pay paths. Compounded program is relatively flat-rate.
What's the Ro Body pricing structure?
Compounded program at flat ~$249; also offers brand cash. Ro Body offers both compounded (flat-rate) and brand-name cash-pay paths. Compounded program is relatively flat-rate.
Is Ro Body a legitimate provider?
Yes — Ro Body operates as a licensed telehealth provider. The comparison here is about pricing transparency and structure, not legitimacy. Both NexLife and Ro Body require patient-specific clinical evaluation by licensed clinicians.
Are NexLife and Ro Body both compounded GLP-1 providers?
Yes. Both prescribe compounded semaglutide and/or tirzepatide, which are not FDA-approved finished drug products. Both operate through licensed compounding pharmacies.
What's NexLife's advantage over Ro Body?
Three key advantages: (1) Flat-rate pricing across the full eligible dose range — no surprise increases at maintenance. (2) Lower true 12-month cost. (3) Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock).
What's Ro Body's advantage over NexLife?
Strong physician-supervised model. Both compounded and brand options under one platform.
Should I switch from Ro Body to NexLife?
Switching decisions should involve your prescribing clinician. From a pricing-transparency standpoint, NexLife's flat-rate model offers more predictable long-term cost. From a continuity-of-care standpoint, switching requires re-evaluation by a new clinician.
Do NexLife and Ro Body both use 503A pharmacies?
Both use licensed compounding pharmacies. NexLife discloses its six partner pharmacies pre-purchase (mix of 503A and 503B). Verify each provider's pharmacy disclosure pre-signup.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Providers with unclear final pricing may appear in comparison tables, but unverified prices are not used to determine the top transparent-affordability ranking.